FGFR 저해제 및 KRAS 저해제를 포함하는 병용 요법

본 개시는 키르스텐 래트 육종[Kirsten rat sarcoma, KRAS] 저해제와 병용하여 섬유아세포 성장 인자 수용체[Fibroblast Growth Factor Receptor, FGFR] 저해제인 화합물을 투여함으로써 암을 치료하는 방법에 관한 것이다. The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor,...

Full description

Saved in:
Bibliographic Details
Main Authors LAW CHUNYIN MARSHALL, ZHAO LE, SHVARTSBART ARTEM, SUSICK ROBERT, LI YONG, WANG XIAOZHAO, POLAM PADMAJA, ARJONA ALEJANDRO AMADOR, MCCAMMANT MATTHEW, POLICARPO ROCCO, SOKOLSKY ALEXANDER, GAN PEI, ZHANG FENGLEI, CARLSEN PETER, YANG JEFFREY C, LI GENCHENG, MIN CHANG, WEE SUSAN, ZHU WENYU, QI CHAO, HE CHUNHONG, YAO WENQING, RIOS DORIA JONATHAN, ROACH JEREMY, YE QINDA, ABDOLLAHI ANGELA, FAVATA MARGARET, YIN HAOLIN, WANG HUI, HOANG GIA, HU BIN
Format Patent
LanguageKorean
Published 13.08.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 개시는 키르스텐 래트 육종[Kirsten rat sarcoma, KRAS] 저해제와 병용하여 섬유아세포 성장 인자 수용체[Fibroblast Growth Factor Receptor, FGFR] 저해제인 화합물을 투여함으로써 암을 치료하는 방법에 관한 것이다. The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor.
Bibliography:Application Number: KR20247020689